InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Clague Laura, Chief Financial Officer. Officer active across 4 companies, notably Travere Therapeutics, Inc.. Cumulatively, 12 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €94k. Activity tracked since 11 May 2021. The latest transaction was filed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Clague Laura
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
26,376 shares0Common StockSEC:0001162194-23-000041:0
30,914 shares0Common StockSEC:0001162194-22-000075:0
825 shares@ US$21.510.0004% mcap9.9% of flowCommon StockSEC:0001209191-22-028707:0
50,000 shares@ US$1.330.077% mcap62.3% of flowCommon StockSEC:0001437749-22-009944:0
30,000 sharesCommon StockSEC:0001437749-22-006570:0
20,000 shares@ US$2.160.047% mcap37.7% of flowCommon StockSEC:0001437749-22-004289:0
9,840 shares0Common StockSEC:0001209191-22-006362:0
2,063 shares@ US$24.9848.4% of flowCommon StockSEC:0001209191-22-005080:0
7,500 shares0Common StockSEC:0001209191-22-003046:0
4,500 shares0Common StockSEC:0001209191-21-052077:0
10,342 shares0Common StockSEC:0001162194-21-000059:0
2,000 shares@ US$19.1433.6% of flowCommon StockSEC:0001209191-21-032314:0
12 of 12 declarations
About Clague Laura
Laura Clague is associated with Travere Therapeutics, Inc.
